Perspective Therapeutics (CATX) Return on Assets (2011 - 2026)
Perspective Therapeutics (CATX) reported Return on Assets of 0.0% for Q1 2026, little changed on a YoY basis from 0.0% in Q1 2025, and down 4681.83% sequentially from 0.0% in Q4 2025.
Perspective Therapeutics (CATX) Return on Assets (2011 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 15 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Assets declined to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q4 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
- Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
- Tracing CATX's Return on Assets over 5 years: stood at 0.0% in 2022, then soared by 64 bps to 0.0% in 2023, then soared by 97 bps to 0.0% in 2024, then soared by 171 bps to 0.0% in 2025, then slumped by 4682 bps to 0.0% in 2026.
- Business Quant data shows CATX's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.00% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.00% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.00% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.00% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 0.00% |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |